NOUVELLES ASSOCIATIONS D'UN INHIBITEUR DE POLYMERISATION DE LA TUBULINE ET D'UN INHIBITEUR DE LA POLY(ADP-RIBOSE) POLYMERASE (PARP) DESTINEES A ETRE UTILISEES DANS LE TRAITEMENT DU CANCER
Methods and combination therapies for treating, preventing, and/or delaying the onset and/or development of cancer using a tubulin polymerization inhibitor such as a compound of formula I,or a pharmaceutically acceptable salt thereof, and a poly (ADP-ribose) polymerase (PARP) inhibitor,or a pharmaceutically acceptable salt thereof, are provided.